Slynd is now available to 95% of the Canadian population under public insurance plans

BLAINVILLE, QC, Feb. 27, 2025 /PRNewswire/ - Duchesnay Inc., a pharmaceutical company specializing in women's health and member of Duchesnay Pharmaceutical Group, winner of the 2024 Life Sciences Innovation Award by ADRIQ, is pleased to announce that Slynd (drospirenone tablets, 4 mg), is...